Three more com­pa­nies price IPOs, bring­ing this year's raise up to $11.78B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

The biotech IPO rush con­tin­ues, as three more com­pa­nies — Nu­va­lent, Icosavax and Rally­bio — priced their pub­lic de­buts on Wednes­day and Thurs­day. So far, 92 com­pa­nies have priced or filed for IPOs this year, rais­ing a mas­sive $11.78 bil­lion and sur­pass­ing last year’s count of 91 pub­lic de­buts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER